News & Events about Iveric Bio Inc.
SHAREHOLDER ALERT: Weiss Law Investigates IVERIC bio, Inc. SHAREHOLDER ALERT: Weiss Law Investigates IVERIC bio, Inc. PR Newswire NEW YORK, May 1, 2023 NEW YORK, May 1, 2023 /PRNewswire/ -- Weiss Lawis investigating possible breaches of fiduciary duty and other violations of law by the board of...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of IVERIC bio, Inc. (NasdaqGS: ISEE) to Astellas Pharma Inc. Under the terms of the proposed transaction, shareholders of IVERIC will receive...
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased ...
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Iveric bio, Inc. (NASDAQ: ISEE)s sale to ...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Iveric bio, Inc. (NASDAQ: ISEE) to Astellas Pharma Inc. for $40.00 per share in cash is fair to Iveric shareholders. Halper Sadeh encourages Iveric shareholders to click here to learn more about their legal rights...